Ravulizumab (Anti-Complement C5)

Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2537
• Sku #: A2537-1mg*5